Skip to main content
Công ty Cổ phần Dược phẩm Imexpharm logo

Công ty Cổ phần Dược phẩm Imexpharm — Investor Relations & Filings

Ticker · IMP ISIN · VN000000IMP0 HSX Manufacturing
Open in API
Filings indexed 382 across all filing types
Latest filing 2021-03-30 Director's Dealing
Country VN Viet Nam
Listing HSX IMP

About Công ty Cổ phần Dược phẩm Imexpharm

www.imexpharm.com

Imexpharm Corporation is a prominent pharmaceutical company with over 48 years of experience in the manufacturing, compounding, and distribution of high-quality pharmaceutical products. The company operates extensive production facilities, including three EU-GMP certified factory clusters and one WHO-GMP certified cluster, making it a leader in EU-GMP compliant manufacturing. Imexpharm is recognized as a top producer of antibiotics and offers a diverse product portfolio encompassing injectable and oral antibiotics, cardiovascular, ophthalmic, musculoskeletal, respiratory, and digestive system treatments, alongside vitamins, minerals, and health protection foods. With 28 product registrations for 11 products in Europe, Imexpharm is dedicated to delivering effective and safe healthcare solutions to the community.

Recent filings

Filing Released Lang Actions
IMP: Thông báo giao dịch cổ phiếu của người nội bộ
Director's Dealing Classification · 95% confidence The document is a formal notice of transaction in shares by an internal person (Phó Tổng Giám đốc) and affiliated persons, disclosing shareholding before and after, transaction type, volume, purpose, and dates. This corresponds to insider trading or director dealings. It is not a corporate buyback (POS) but a personal transaction disclosure by a senior executive, fitting the 'Director's Dealing' category (DIRS).
2021-03-30 Vietnamese
IMP: Thông báo giao dịch cổ phiếu của người có liên quan đến người nội bộ Trần Thị Hồng
Director's Dealing Classification · 95% confidence The document is a regulatory notice disclosing personal transactions in shares/fund certificates/covered warrants by an internal person and affiliated persons. It details insider share sales, quantities, transaction method, purpose, and reporting obligations. This matches the definition of Director's Dealing (insider trades by company directors/executives).
2021-03-30 Vietnamese
IMP: Thông báo giao dịch cổ phiếu của người có liên quan đến người nội bộ Hồ Thị Thanh Thoại
Director's Dealing Classification · 93% confidence The document is a Vietnamese/English bilingual “Thông Báo” (Notice) of share transactions by an internal person and affiliated persons, detailing director name, share quantities before and after, purpose, transaction period, etc. This matches an insider/ director personal share transaction report. Therefore, it is classified as Director’s Dealing (insider trades).
2021-03-30 Vietnamese
IMP: Báo cáo kết quả giao dịch cổ phiếu của người có liên quan đến người nội bộ Trần Thị Hồng
Director's Dealing Classification · 92% confidence The document is a formal report filed with the securities commission and stock exchange detailing the share transactions (purchase/sale) carried out by an internal person (a director/executive) and their affiliated person. It includes insider’s name, positions, securities code, number of shares before and after the trade, transaction method, dates, and value. This matches the definition of a Director’s Dealing filing (insider transactions).
2021-03-29 Vietnamese
IMP: Nghị quyết HĐQT số 05 ngày 15/03/2021
Board/Management Information Classification · 87% confidence The document is a 24-hour disclosure to the Vietnamese SEC and HoSE containing a Board of Directors resolution (Nghị quyết HĐQT) that establishes an internal audit function and changes responsibilities and personnel of the internal audit and risk subcommittee. It is an announcement of management/board decisions and changes in senior governance structure. This clearly falls under “Board/Management Information” (Code: MANG).
2021-03-15 Vietnamese
IMP: Thông báo ngày ĐKCC tổ chức ĐHĐCĐ thường niên năm 2021
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is a stock exchange announcement from HOSE regarding the “ngày đăng ký cuối cùng” (record date) for entitling shareholders to attend and vote at the 2021 Annual General Meeting of Imexpharm (IMP). It details the ex-rights date, record date, purpose (AGM), voting ratio, and meeting agenda. This is an official Voting Rights Announcement, best classified under Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-03-09 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.